US Patent Issued to THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES on Nov. 25 for "D3 receptor agonist compounds; methods of preparation; intermediates thereof; and methods of use thereof" (Maryland Inventors)

ALEXANDRIA, Va., Nov. 25 -- United States Patent no. 12,479,838, issued on Nov. 25, was assigned to THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (Bethesda, Md.).

"D3 receptor agonist compounds; methods of preparation; intermediates thereof; and methods of use thereof" was invented by Amy Hauck Newman (Bethesda, Md.), Alessandro Bonifazi (Bethesda, Md.), Francisco Oscar Battiti (Bethesda, Md.) and Sophie L. Cemaj (Bethesda, Md.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are novel compounds including dopamine D3 receptor agonists, compositions thereof, methods of use thereof, and processes of synthesizing the same. Further disclosed...